Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Medtronic and Biosense Webster agree collaboration plan to advance care for cardiac arrhythmias

Medtronic : 07 May, 2007  (New Product)
Medtronic and Biosense Webster plans to collaborate on implementing a clinical trial, educational initiatives and a product development programme aimed at cardiac patients.
All of the collaboration projects are aimed at advancing the care of patients with cardiac arrhythmias, also known as irregular heartbeats.

The initiative was announced to coincide with the start of Heart Rhythm 2007, the Heart Rhythm Society's 28th Annual Scientific Sessions, taking place in Denver May 9 to 12 2007.

Heart Rhythm 2007 is the premier medical and scientific conference for electrophysiologists.

'We are pleased to collaborate with Medtronic in this important endeavor', said Roy Tanaka, president, Biosense Webster.

'This new strategic alliance will leverage the unique resources and technologies of the two companies together, and will benefit the millions of patients who suffer from cardiac arrhythmias around the world'.

Under the terms of the agreement, the two companies plan to collaborate on three key areas of interest - a clinical trial, a technology development initiative and educational programmes.

The companies intend to design the clinical trial to create a new care pathway for identifying candidates most likely to have a successful ablation treatment outcome and increase the acceptance of ablation therapy.

'Medtronic is intently focused on researching and exploring ways to utilise existing or new technologies for electrophysiologists to better identify and treat patients with cardiac arrhythmias', said Steve Mahle, president of Medtronic's Cardiac Rhythm Disease Management business.

'This collaboration will begin by bringing the unique competencies of imaging and navigation together with diagnostics and monitoring in an effort to improve the electrophysiologist's capability in identifying and treating patients'.

'We look forward to collaborating with Biosense Webster to deliver exciting results for our customers'.

In addition, the two companies will work together to advance patient care through a joint research and development programme.

The companies plan to integrate specific technologies to provide novel, new solutions for the treatment of complex cardiac arrhythmias.
Lifetime education of physicians is a hallmark of both Biosense Webster and Medtronic.

Through this relationship, the companies will collaborate to combine resources to extend existing educational opportunities as well as create new instructional programmes for electrophysiologists and allied health professionals who work in the arrhythmias field.

'With Biosense Webster, we can continue our commitment to education of physicians at all stages of their career', said Mahle.

'The field of electrophysiology is always changing and advancing and it is vital that physicians and other health care professionals who work in this field are up to date on the latest technologies designed to help patients'.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo